Crystal's MCW Coder Hub🩺 CPT 52649 - Laser Enucleation of Prostate with Morcellation
Short Descriptor
Laser enucleation of prostate with morcellation
Full Descripton
Laser enucleation of the prostate with morcellation, including control of postoperative bleeding, complete (vasectomy, meatotomy, cystourethroscopy, urethral calibration and/or dilation, internal urethrotomy, and transurethral resection of the prostate are included if performed)
Code Tree / Hierarchy
Surgery (10000-69999)
└── Urinary System (50010-53899)
└── Bladder (51020-52700)
└── Vesical Neck and Prostate (52400-52700)
└── Laser Procedure of Prostate - Complete (52647-52649)
├── 52647 - Laser coagulation of prostate ⛔ DELETED 2026
├── 52648 - Laser vaporization of prostate ✅ Active 2026
└── 52649 - Laser enucleation with morcellation ✅ Active 2026
Clinical Overview
CPT 52649 describes laser enucleation of the prostate with morcellation, most commonly performed as Holmium Laser Enucleation of the Prostate (HoLEP), though thulium fiber laser (ThuFLEP) and diode laser techniques may also be documented. This is a transurethral endoscopic procedure performed under direct visualization via a resectoscope or continuous-flow scope passed through the urethra.
This procedure is considered size-independent — particularly advantageous for large-volume prostates (>80g) where standard TURP would carry higher risk of bleeding and incomplete resection. It is one of the most durable and effective surgical interventions for bladder outlet obstruction due to BPH and is associated with low retreatment rates.
Surgical Technique Summary
- A resectoscope is passed transurethrally into the bladder
- The surgeon uses a high-powered laser (typically Holmium:YAG at 2,100 nm) to enucleate the prostatic adenoma from the surgical capsule in defined lobes (usually 2 or 3 lobes)
- The enucleated tissue is pushed entirely into the bladder
- A morcellator is introduced into the bladder to mechanically fragment the enucleated tissue into small pieces suitable for evacuation
- Fragments are aspirated out of the bladder
- Hemostasis is confirmed and controlled
- A urethral catheter is placed at procedure end
Includes - Bundled Services
The following services are explicitly included in the CPT 52649 descriptor per the AMA and must NOT be billed separately when performed during the same operative session:
| Bundled Procedure | CPT Code(s) | Notes |
|---|---|---|
| Vasectomy | 55250 | Included if performed |
| Meatotomy | 53020 / 53025 | Included if performed |
| Cystourethroscopy | 52000 | Always included — never separately bill |
| Urethral calibration and/or dilation | 52281 / 52285 | Included if performed |
| Internal urethrotomy | 52270 / 52275 | Included if performed |
| Transurethral resection of the prostate (TURP) | 52601 | Included if performed |
| Control of postoperative bleeding | — | Always included in the global package |
Note
⚠️ Billing any of the above procedures separately when performed as part of 52649 constitutes unbundling and is a compliance risk.
Related & Excluded CPT Codes
| CPT | Description | Relationship to 52649 |
|---|---|---|
| 52647 | Laser coagulation of prostate | DELETED January 1, 2026 - No longer valid |
| 52648 | Laser vaporization of prostate (complete) | Sibling code - different laser technique; vaporization vs. enucleation |
| 52601 | TURP - complete | Bundled into 52649 if performed same session |
| 52630 | TURP - residual or regrowth | Different scenario: prior prostatectomy site |
| 52640 | TURP - postoperative bladder neck contracture | Different indication: post-op contracture |
| 52597 | Aquablation - robotic waterjet resection | New CPT code effective 2026; previously Category III (0421T) |
| 53850 | TUNA - radiofrequency thermotherapy | Alternative technology; different approach |
| 53854 | Waterjet thermotherapy (Rezum) | Alternative technology |
| 55801 | Prostatectomy, perineal | Open surgical approach - different family |
| 55840-55845 | Retropubic prostatectomy / radical | Open or radical; different code family |
| 52000 | Cystourethroscopy (diagnostic) | Bundled - do NOT separately report |
| 55700 | Prostate needle biopsy | May be separately reportable in distinct scenarios - check NCCI |
| 88305 | Surgical pathology - prostate resection | Separately reportable when specimen sent to pathology |
RVU & Reimbursement (2026)
All values are national averages before Geographic Practice Cost Index (GPCI) adjustments. Always verify with the CMS MPFS Lookup Tool at cms.gov and your local MAC.
Physician Fee Schedule (Professional Component)
| Metric | Value | Notes |
|---|---|---|
| wRVU - 2026 Finalized | 13.00 | Reflects CMS -2.5% efficiency adjustment + revaluation |
| wRVU - 2025 / Pre-Adjustment | ~19.67 | Prior to CMS 2026 efficiency revaluation |
| RUC Recommended wRVU (2026) | 14.56 | CMS departed from RUC recommendation |
| CMS 2026 Conversion Factor (Qualifying APM) | $33.57 | +3.77% from 2025 |
| CMS 2026 Conversion Factor (Non-Qualifying APM) | $33.40 | +3.26% from 2025 |
| Estimated Facility Physician Payment (National) | ~$437 | 13.00 × $33.57; before GPCI |
| Global Period | 090 days | Major surgery global package |
| Multiple Procedure Indicator | 2 | Subject to standard multiple procedure reduction |
| Bilateral Surgery Indicator | N/A | Not applicable |
Note
⚠️ Important for wRVU-Based Compensation: The 2026 wRVU of 13.00 represents a ~34% reduction from the prior 2025 value of ~19.67. Practices with provider compensation tied to wRVU benchmarks will see significant impacts for this procedure. Budget accordingly.
Outpatient Facility Payment
| Setting | APC | Status Indicator | 2026 Payment |
|---|---|---|---|
| Hospital Outpatient (HOPD) | APC 5375 | J1 | ~$5,478 |
| Ambulatory Surgical Center (ASC) | — | J1 | ~$2,730 |
| Inpatient - MS-DRG 713 | DRG 713 | w/ CC/MCC | Varies by hospital/region |
| Inpatient - MS-DRG 714 | DRG 714 | w/o CC/MCC | Varies by hospital/region |
Note
APC Status Indicator J1 = Hospital Part B services paid under OPPS; subject to the composite APC payment policy.
Global Period & Post-Op Billing
- Global Period: 090 days (major surgery)
- Pre-op day-of-procedure E/M: Included in global package unless the E/M is for a separate, unrelated condition (use modifier -25 on the E/M code)
- Post-operative visits (90 days): Included in the global package — do not bill separately
- Complications requiring return to OR during global period: Use modifier -78 (unplanned) or -58 (planned/staged)
- Unrelated E/M visit during global period: Use modifier -24 on the E/M code
- Unrelated surgical procedure during global period: Use modifier -79 on the procedure code
Assistant at Surgery
| Indicator | Value |
|---|---|
| Assistant at Surgery | Permitted - Indicator 1 |
| MD/DO Assistant Modifier | -80 - Assistant Surgeon |
| MD Assistant (No Qualified Resident Available) | -82 |
| PA-C / NP / CNS as Assistant | -AS - Assistant at Surgery (Medicare) |
| Co-Surgery | Not applicable |
| Team Surgery | Not applicable |
Note
Medicare reimburses assistant surgeons at 16% of the primary surgeon’s allowed amount when modifier -80 or -82 is used. When modifier -AS is used, Medicare pays 85% of the physician assistant fee schedule amount (which is itself 85% of the physician rate), resulting in approximately 72% of the physician fee. Always verify individual payer policies for commercial insurance — not all commercial payers follow Medicare guidelines.
HCC Status & Risk Adjustment
CPT procedure codes themselves do not carry HCC (Hierarchical Condition Category) risk adjustment values. HCC status applies to ICD-10-CM diagnosis codes reported on the claim. The following is provided to assist with complete and accurate diagnosis coding.
| ICD-10-CM Code | Description | HCC Status | HCC Category |
|---|---|---|---|
| N40.0 | BPH without LUTS | ❌ Not HCC | Not risk-adjustable |
| N40.1 | BPH with LUTS | ❌ Not HCC | Not risk-adjustable |
| N40.2 | Nodular prostate without LUTS | ❌ Not HCC | Not risk-adjustable |
| N40.3 | Nodular prostate with LUTS | ❌ Not HCC | Not risk-adjustable |
| C61 | Malignant neoplasm of prostate | ✅ HCC-12 | Prostate cancer - risk adjustable |
| N18.3- | CKD Stage 3a/3b | ✅ HCC-329 | CKD - may be concurrent |
| N18.4 | CKD Stage 4 | ✅ HCC-328 | CKD - may be concurrent |
| E11.65 | Type 2 DM with hyperglycemia | ✅ HCC-37 | Diabetes - may be concurrent |
Note
💡 While BPH procedures are not HCC-driven, complete diagnosis coding of all chronic conditions (documented and clinically managed during the encounter) supports accurate risk adjustment scores, quality reporting, and correct MS-DRG assignment.
MS-DRG Assignment
MS-DRG assignment for inpatient claims is driven by the principal diagnosis + procedure code combination + presence of CCs and MCCs. The values below represent typical, expected assignments for 52649 as a hospital inpatient procedure.
| MS-DRG | Description | Key Driver |
|---|---|---|
| 713 | Transurethral Prostatectomy with CC or MCC | Comorbidities like UTI, retention, DM, CKD |
| 714 | Transurethral Prostatectomy without CC or MCC | Otherwise uncomplicated BPH case |
Note
💡 Accurately documenting and coding all clinically supported comorbidities (e.g., urinary retention, hematuria, diabetes, CKD, hypertensive heart disease) can affect DRG assignment and facility reimbursement. Query the physician when documentation is unclear.
Common Modifiers
| Modifier | Description | When to Use with 52649 |
|---|---|---|
| -22 | Increased Procedural Services | Document when significantly more complex than typical (e.g., very large prostate >150g, adhesions from prior radiation/surgery, prolonged operative time); requires supporting documentation and often payer review |
| -51 | Multiple Procedures | When 52649 is performed on the same day as another unrelated surgical procedure; subject to multiple procedure reduction |
| -52 | Reduced Services | Procedure started but not fully completed (less drastic than -53); e.g., partial enucleation only |
| -53 | Discontinued Procedure | Procedure discontinued after anesthesia induction due to extenuating circumstances posing risk to patient; document extensively |
| -58 | Staged or Related Procedure | Planned return to OR within the global period for a staged or related procedure |
| -59 | Distinct Procedural Service | Use cautiously for NCCI override; prefer -XE, -XS, -XP, or -XU modifiers when applicable |
| -78 | Unplanned Return to OR | Complication requiring return to OR within global period (e.g., postoperative hemorrhage, clot retention) |
| -79 | Unrelated Procedure During Global | Unrelated surgical procedure performed during the 90-day global period |
| -80 | Assistant Surgeon | MD/DO acting as assistant surgeon to the primary operating urologist |
| -82 | Assistant - No Qualified Resident | Used in teaching hospital settings when a qualified resident surgeon is not available |
| -AS | APP as Assistant at Surgery | PA-C, NP, or CNS assisting the primary surgeon (Medicare and most Medicaid) |
Commonly Paired ICD-10-CM Diagnosis Codes
Report the most specific diagnosis code supported by documentation. The following reflect the most common medical necessity diagnoses for CPT 52649.
| ICD-10-CM | Description | Notes |
|---|---|---|
| N40.1 | Benign prostatic hyperplasia with LUTS | 🔑 Primary diagnosis - most common; use when LUTS documented |
| N40.0 | Benign prostatic hyperplasia without LUTS | Use only when LUTS are explicitly absent or not documented |
| N40.2 | Nodular prostate without LUTS | Nodular pattern confirmed; asymptomatic |
| N40.3 | Nodular prostate with LUTS | Nodular prostate + documented urinary symptoms |
| R33.8 | Other retention of urine | Acute or chronic urinary retention; often MCC/CC in inpatient |
| R33.9 | Retention of urine, unspecified | Use when retention is documented but not further specified |
| N13.8 | Other obstructive and reflux uropathy | BPH with hydronephrosis/upper tract effects |
| R35.0 | Frequency of micturition | Symptom code supporting LUTS — use with N40.1 |
| R35.1 | Nocturia | Symptom code supporting LUTS — use with N40.1 |
| R39.12 | Poor urinary stream | Supports LUTS documentation |
| R39.14 | Feeling of incomplete bladder emptying | Supports LUTS documentation |
| N21.0 | Calculus in bladder | Use if concurrent bladder stone removed during same session |
| C61 | Malignant neoplasm of prostate | If procedure addresses prostate malignancy or obstruction due to cancer |
| N99.820 | Postprocedural hemorrhage of urinary system organ | Use for return visits/procedures related to post-HoLEP bleeding |
Coding Examples / Scenarios
Scenario 1 - Routine HoLEP for BPH with LUTS (Outpatient)
Clinical Situation: A 68-year-old male with well-documented BPH and lower urinary tract symptoms including nocturia, weak stream, and urgency. AUA Symptom Score 22 (severe). Urologist performs HoLEP with morcellation in the ASC. During the procedure, cystourethroscopy and urethral calibration are also performed.
Report:
52649- Laser enucleation of prostate with morcellation
ICD-10-CM:
N40.1- Benign prostatic hyperplasia with lower urinary tract symptomsR35.1- Nocturia (optional supporting symptom code)R39.12- Poor urinary stream (optional supporting symptom code)
❌ Do NOT separately bill 52000 (cystourethroscopy) or 52281 (urethral dilation) — both are bundled into 52649 per the descriptor.
Scenario 2 - HoLEP with Concurrent Bladder Stone Removal
Clinical Situation: During the same operative session, the urologist discovers and removes a 3.0 cm bladder calculus using a laser lithotripsy technique prior to performing the laser enucleation of the prostate.
Report:
52649- Laser enucleation of prostate with morcellation52318-51- Litholapaxy; large (over 2.5 cm) (with multiple procedure modifier)
ICD-10-CM:
N40.1- BPH with LUTSN21.0- Calculus in bladder
✅ Bladder stone removal (52318) is a distinct procedure and is NOT bundled into 52649 — it may be separately reported with appropriate modifier and documentation. 🔍 Always verify NCCI Procedure-to-Procedure (PTP) edits before billing these together.
Scenario 3 - Assistant Surgeon / APP Billing
Clinical Situation: A urological PA-C assists the attending urologist during a HoLEP procedure performed in the hospital outpatient department.
Primary Surgeon Reports:
52649- No modifier needed for the primary surgeon
PA-C (Assistant) Reports:
52649-AS- Assistant at Surgery
Medicare pays the assistant at approximately 72% of the physician rate when modifier -AS is used. Verify commercial payer policies separately.
Scenario 4 - Procedure Discontinued After Anesthesia Induction
Clinical Situation: A 74-year-old male develops hemodynamic instability following spinal anesthesia induction for HoLEP. The urologist begins the procedure (scope inserted, initial visualization) but discontinues before laser enucleation can be completed due to patient safety concerns.
Report:
52649-53- Discontinued procedure
📝 Document: the reason for discontinuation, the point at which the procedure was stopped, and the clinical risk to the patient. Attach the operative report to the claim. Reimbursement will be significantly reduced.
Scenario 5 - Unplanned Return to OR for Postoperative Hemorrhage (Within Global Period)
Clinical Situation: On post-op day 4 following HoLEP, the patient presents with gross hematuria and clot retention. The urologist returns him to the OR for cystoscopy with clot evacuation and fulguration.
Report:
52001-78- Cystourethroscopy with irrigation and evacuation of multiple obstructing clots (modifier -78: unplanned return to OR, related procedure during global period)
ICD-10-CM:
N99.820- Postprocedural hemorrhage of a urinary system organ or structure following a procedure
⚠️ Modifier -78 signals to the payer this is a return to OR for a related complication within the global period of 52649. Reimbursement is typically paid at the facility rate for the new procedure, and does not reset the global period.
Scenario 6 - Inpatient Admission with Comorbidities (Facility Coding)
Clinical Situation: A 72-year-old male is admitted to inpatient for HoLEP due to BPH with acute urinary retention and a history of type 2 diabetes with hyperglycemia and CKD Stage 3b (eGFR 38). Attending documents and addresses all comorbidities.
ICD-10-CM (Inpatient Sequencing):
N40.1- BPH with LUTS (principal diagnosis)R33.8- Other retention of urine (secondary — confirm CC/MCC status with payer)E11.65- Type 2 DM with hyperglycemia (CC)N18.32- CKD Stage 3b (CC)
CPT (Professional Claim):
52649- Laser enucleation of prostate with morcellation
Expected MS-DRG: 713 - Transurethral Prostatectomy with CC/MCC (driven by diabetes + CKD comorbidities)
💡 Capturing the comorbidities accurately upgrades this case to DRG 713 vs. 714, which carries a higher facility reimbursement weight. Query the attending for specificity if documentation is vague.
Scenario 7 - Surgical Pathology Add-On
Clinical Situation: After HoLEP, the enucleated prostatic tissue (all lobes) is submitted to surgical pathology. The pathology report is generated by the same group.
Professional Pathology Charge:
88305- Surgical pathology, gross and microscopic examination — Prostate, needle biopsy/TURP/enucleation
✅ 88305 is separately billable by the pathology group/physician and is NOT bundled into the surgical 52649 fee. The pathology report may incidentally reveal prostate adenocarcinoma — if found, ensure the diagnosis is subsequently updated and coded appropriately on future encounters.
Documentation Requirements
To support medical necessity and accurate billing of CPT 52649, the operative report should clearly reflect:
- Indication: BPH, LUTS, urinary retention, bladder outlet obstruction, or other medically necessary diagnosis
- Approach: Transurethral, endoscopic
- Laser type and settings: e.g., Holmium:YAG laser, specific wattage/energy settings
- Enucleation confirmed: Documentation that the entire prostatic adenoma (all lobes) was enucleated from the surgical capsule
- Morcellation documented: Explicit mention of morcellator use and tissue evacuation
- Hemostasis confirmed: Control of bleeding during and at the end of the procedure
- Any additional procedures performed: Even if bundled, document them — state they are part of the same operative session
- Catheter placement: Foley catheter placed at end of procedure
- Estimated blood loss
- Specimen disposition: Confirmation that tissue was sent to pathology
- Anesthesia type
Note
⚠️ Missing documentation of morcellation specifically may result in downcoding to 52648 (laser vaporization). The distinction is critical — enucleation + morcellation = 52649; vaporization = 52648.
Coding Tips & Pitfalls
💡 52647 is DELETED in 2026. Do not use this code for any claims with dates of service on or after January 1, 2026. There is no grace period. Verify the correct laser technique and select 52648 or 52649 based on documentation.
💡 Laser mentioned ≠ automatic 52649. Just because the operative note mentions a laser does not default to 52649. The documentation must specifically describe: (1) enucleation of the adenoma from the capsule AND (2) morcellation of the tissue. Vaporization-only = 52648.
💡 Do not unbundle cystourethroscopy. 52000 is always included in 52649 and should never be reported separately on the same date of service regardless of how the operative note is structured.
💡 Modifier -22 opportunity. For very large prostates (>150g adenoma weight documented), significantly prolonged operative times, or unexpected surgical complexity (prior radiation fibrosis, severe adhesions), modifier -22 may be appropriate. Attach a cover letter and the operative report to the claim.
💡 **wRVU productivity impact